|1.||Chandran, Bala: 9 articles (08/2015 - 01/2003)|
|2.||Knipe, David M: 7 articles (05/2015 - 09/2005)|
|3.||Coen, Donald M: 7 articles (10/2014 - 11/2002)|
|4.||Binda, Sandro: 7 articles (06/2014 - 07/2004)|
|5.||Yoshikawa, Tetsushi: 7 articles (03/2014 - 01/2002)|
|6.||Doorbar, John: 6 articles (08/2014 - 02/2004)|
|7.||Tsurumi, Tatsuya: 6 articles (07/2014 - 12/2004)|
|8.||Yu, Dong: 6 articles (01/2014 - 09/2006)|
|9.||Moss, Bernard: 6 articles (10/2012 - 09/2003)|
|10.||Barbi, Maria: 6 articles (01/2012 - 07/2004)|
02/01/2015 - "When added up to 1h after infection, it dramatically reduced CMV immediate early protein expression and blocked viral DNA synthesis. "
01/01/2011 - "Whereas plants infected with either virus (single infection) presented a remission stage with a corresponding decrease in viral DNA levels, double-infected plants did not present symptom remission and both viral DNA concentrations dramatically increased. "
11/01/1994 - "Agroinoculation of the C4 mutant TLCV into three alternative experimental hosts for the virus (Datura stramonium, Lycopersicon esculentum, and Nicotiana tabacum) gives rise to infections which show dramatically reduced symptoms when compared to a wild-type infection, while retaining wild-type levels of all viral DNA species. "
12/01/2009 - "The gold standard for diagnosis of congenital CMV infection is the detection of the virus in urine within the first 2 weeks of life by rapid cell culture techniques (shell vial) or nucleic acid amplification of viral DNA (PCR). "
02/26/2002 - "The results show that expression of the IIIa protein during the early phase of infection results in a significant reduction in late viral protein synthesis and a moderate block to viral DNA replication. "
|2.||Chronic Hepatitis B
01/01/2013 - "Pretreatment viral DNA stratifies mortality risk in patients receiving antiviral therapy for severe acute exacerbation of chronic hepatitis B."
05/01/2009 - "Viral DNA was extracted from 227 serum samples of chronic hepatitis B patients from September, 2005 to March, 2007. "
01/01/2001 - "Nucleoside analogues are promising drugs in the treatment of chronic hepatitis B through inhibition of viral DNA polymerase. "
01/01/2015 - "This study evaluated the relationship between liver hepatitis B DNA viral load with liver histology in patients with chronic hepatitis B (HBV). "
01/01/2015 - "Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B."
12/01/1985 - "These studies indicate that the major reservoir of unit-length viral DNA in the asymptomatic hepatitis B carriers studied here was in the polymorphonuclear leukocyte fraction. "
07/01/2014 - "We evaluated the correlation between age and hepatitis B viral DNA levels with Metavir score in inactive chronic HBV carriers. "
11/01/2013 - "All the anti-HBc positivesubjects had detectable hepatitis B viral DNA in their serum. "
11/01/2013 - "Molecular detection of hepatitis B viral DNA was performed using nested polymerase chain reaction. "
03/01/2013 - "Presence of hepatitis B viral DNA was checked in HBcAb positive samples by nested PCR with two sets of primers to amplify part of HBV S gene. "
09/15/2012 - "Patients developed increased levels of viral DNA in the circulation originating from apoptotic tumor cells, had disease stabilization, and experienced improved quality of life. "
07/01/2015 - "Many studies reported higher viral DNA prevalence in tumor tissues than in normal noncancerous tissues either in the same patients or in CRC-free controls. "
01/01/2014 - "In this view, several studies investigated tumor samples for the presence of various viral DNA with conflicting results. "
11/01/2010 - "Using PCR primers developed from these genomic DNA sequences, studies were then carried out in order to identify the frequency at which the viral DNA could be identified in equine genital cancer samples from horses in both the UK, Australia and Austria. "
05/12/2006 - "This study validates a novel strategy in which modifications of viral DNA polymerases in various vector systems allow the delivery of target genes exclusively to tumor cells exploiting elevated cellular dNTP concentration as a tumor cell-specific host factor."
03/01/2004 - "Resolution of nephropathy led to resolution of viremia, decreased viruria levels, and disappearance of viral inclusions, but low-level viral DNA persisted in biopsy specimens even for patients whose viruria was cleared. "
05/01/2015 - "Proof-of-concept studies in vitro and in animal models demonstrated bNAbs' ability to block viral entry into cells, suppress viremia and reduce cell-associated viral DNA. "
05/01/2002 - "An in vivo study involving HBV-infected ducks showed that longer administration of L-Fd4C induced a sustained suppression of viremia (>95%) and of viral DNA synthesis in the liver. "
07/01/2015 - "Polymerase chain reaction (PCR) testing confirmed viremia with 8,900 copies/mL viral DNA. "
01/01/2015 - "For both groups, primary viremia (indicated by viral DNA) was seen on days 6-9 through day 17. "
|1.||DNA (Deoxyribonucleic Acid)
|4.||Hepatitis B e Antigens
|8.||RNA (Ribonucleic Acid)
|1.||Transplantation (Transplant Recipients)
|3.||Highly Active Antiretroviral Therapy (HAART)
|4.||Heterologous Transplantation (Xenotransplantation)